 |
|
Bariatric surgery may resolve liver disease
December 01, 2008Obesity is a growing epidemic in the U.S. with a significant increase in prevalence from 15 percent to 32.9 percent from 1980 to 2004. Nonalcoholic fatty liver disease (NAFLD) is an emerging problem related to the obesity epidemic, becoming one of the most common causes of liver disease in the nation.
Bariatric surgery has become a popular and effective method for rapid and permanent significant weight loss in morbidly obese individuals. A recent study reports bariatric surgery results in improvement of histopathological features of NAFLD. Complications of NAFLD, including steatosis, steatohepatitis and fibrosis appeared to improve or completely resolve in a majority of patients after bariatric surgery-induced weight loss, according to results of a study published in Clinical Gastroenterology and Hepatology, an official journal of the American Gastroenterological Association (AGA) Institute.
"Even today, the effect of weight loss after bariatric surgery on the liver, particularly NAFLD, remains unclear. There is a lack of well-defined trials exploring this relationship," said Gagan K. Sood, MD, of the University of Texas Medical Branch and lead author of the study. "Our team assessed and quantified this effect and found encouraging news: a majority of patients experience complete resolution of NAFLD after bariatric surgery, and the risk of progression of inflammatory changes and fibrosis seems to be minimal."
For this meta-analysis, 15 studies were selected for final data extraction. The mean age of the participants at the time of weight loss surgery ranged from 35.6 to 49 years. Mean BMI at the time of weight loss surgery ranged from 43.9 to 56 kg/m2 and the mean BMI at follow-up liver biopsies ranged from 28.6 to 39kg/m2. Percentage reduction in mean BMI values ranged from 19.11 to 41.76.
The pooled proportion of patients with improvement or resolution in steatosis was 91.6 percent, steatohepatitis was 81.3 percent, fibrosis was 65.5 percent and complete resolution of NASH was 69.5 percent.
Generalizability of these results may require confirmation from multi-center, large scale, well designed trials. Future studies need to be done using uniform histopathological criteria for liver biopsy specimens.
NAFLD encompasses a range of conditions involving the liver that affect people who drink little or no alcohol. The spectrum of NAFLD ranges from hepatic steatosis (fat accumulation in the liver cells) to the more severe non-alcoholic steatohepatitis (NASH) and fibrosis that can progress to cirrhosis, end-stage liver disease, and hepatocellular carcinoma. Prevalence of NAFLD is estimated to be around 70 percent in obese individuals and 85 percent to 95 percent in patients with morbid obesity. The prevalence of NASH is as high as 18.5 percent in obese individuals and 33 percent in those who are morbidly obese. The pathophysiologic mechanisms of NAFLD have not been clearly elucidated as yet, but obesity and insulin resistance are considered to be the main causative factors.
American Gastroenterological Association
For this meta-analysis, 15 studies were selected for final data extraction. The mean age of the participants at the time of weight loss surgery ranged from 35.6 to 49 years. Mean BMI at the time of weight loss surgery ranged from 43.9 to 56 kg/m2 and the mean BMI at follow-up liver biopsies ranged from 28.6 to 39kg/m2. Percentage reduction in mean BMI values ranged from 19.11 to 41.76.
The pooled proportion of patients with improvement or resolution in steatosis was 91.6 percent, steatohepatitis was 81.3 percent, fibrosis was 65.5 percent and complete resolution of NASH was 69.5 percent.
Generalizability of these results may require confirmation from multi-center, large scale, well designed trials. Future studies need to be done using uniform histopathological criteria for liver biopsy specimens.
NAFLD encompasses a range of conditions involving the liver that affect people who drink little or no alcohol. The spectrum of NAFLD ranges from hepatic steatosis (fat accumulation in the liver cells) to the more severe non-alcoholic steatohepatitis (NASH) and fibrosis that can progress to cirrhosis, end-stage liver disease, and hepatocellular carcinoma. Prevalence of NAFLD is estimated to be around 70 percent in obese individuals and 85 percent to 95 percent in patients with morbid obesity. The prevalence of NASH is as high as 18.5 percent in obese individuals and 33 percent in those who are morbidly obese. The pathophysiologic mechanisms of NAFLD have not been clearly elucidated as yet, but obesity and insulin resistance are considered to be the main causative factors.
American Gastroenterological Association
Liver Disease Current Events and Liver Disease News RSSAlcohol Tolerance Switch Found in Fruit Flies
Researchers at North Carolina State University have found a genetic "switch" in fruit flies that plays an important role in making flies more tolerant to alcohol.
Scientists develop novel method to generate functional hepatocytes for drug testing
Scientists have for the first time produced liver cells from adult skin cells using the induced pluripotent stem cell (iPSC) technology.
UCSD researchers pave the way for effective liver treatments
A combination of bioengineering and medical research at the University of California, San Diego has led to a new discovery that could pave the way for more effective treatments for liver disease.
Governor recognizes stem cell research at Einstein
Albert Einstein College of Medicine of Yeshiva University hosted a roundtable discussion on stem cell research with New York Governor David A. Paterson today.
Liver cells grown from patients' skin cells
Scientists at The Medical College of Wisconsin in Milwaukee have successfully produced liver cells from patients' skin cells opening the possibility of treating a wide range of diseases that affect liver function.
Metabolic syndrome linked to liver disease in obese teenaged boys
Researchers studying a large sample of adolescent American boys have found an association between metabolic syndrome, which is a complication of obesity, and elevated liver enzymes that mark potentially serious liver disease.
Penn State College of Medicine research isolates liver cancer stem cells prior to tumor formation
Penn State College of Medicine researchers, in collaboration with colleagues at the University of Southern California, have taken an important step in understanding the role of stem cells in development of liver cancer.
Genetic hint for ridding the body of hepatitis C
More than seventy percent of people who contract Hepatitis C will live with the virus that causes it for the rest of their lives and some will develop serious liver disease including cancer.
HBV genotype B/B3 and C/C1 are the major genotypes in Indonesia?
Previous studies revealed that HBV genotypes as well as mutations in the core promoter, precore or HBx gene have been shown to have an association with the clinical outcome of liver disease, however, this is still controversial.
Second-hand smoking results in liver disease, study finds
A team of scientists at the University of California, Riverside has found that even second-hand tobacco smoke exposure can result in nonalcoholic fatty liver disease (NAFLD), a common disease and rising cause of chronic liver injury in which fat accumulates in the liver of people who drink little or no alcohol.
More Liver Disease Current Events and Liver Disease News Articles
 |
The First Year: Cirrhosis: An Essential Guide for the Newly Diagnosed (First Year, The) by James L. Dickerson (Author), Fredric Regenstein (Foreword) More than 25 million Americans and 92 million worldwide suffer from liver disease and cirrhosis, a degenerative and potentially fatal condition in which liver cells are damaged and then replaced by scar tissue, impeding liver function. The disease is most commonly caused by excessive alcohol consumption, hepatitis, or complications from prescription drugs. Immediately after his diagnosis, James Dickerson set out to educate himself on all of his options — and found there is hope for recovery. Now, he offers The First Year: Cirrhosis, the first guide for patients and their families to understanding and managing this chronic condition. In clear, accessible language, the book walks readers step-by-step through everything they need to do each day of the first week after a cirrhosis... |
 |
Dr. Melissa Palmer's Guide To Hepatitis and Liver Disease by Melissa Palmer (Author) In the United States alone, more than four million people are infected with the hepatitis C virus, and chronic liver disease is the twelfth leading cause of death. In this revised and updated edition of her groundbreaking 2000 book, renowned hepatologist Dr. Melissa Palmer discusses all facets of liver disease, from symptoms and tests to treatment options and lifestyle changes. In addition, this comprehensive handbook reveals cutting-edge research on the dangers of hepatitis C, one of the world's fasting-growing microbial threats. |
 |
The Liver Book: A Comprehensive Guide to Diagnosis, Treatment, and Recovery by Sanjiv Chopra (Author) It is the portal to total body wellness, the great purifier, and the only human organ that can regenerate itself. But what you don't know about the liver can hurt you! Now, in this complete and authoritative guide that anyone can use and understand, Dr. Sanjiv Chopra explains: The what, where, how, and why of the liver and its miraculous functions |
 |
The Liver Disorders and Hepatitis Sourcebook (Sourcebooks) by Howard Worman (Author) The latest information on living with and treating liver disorders The Liver Disorders and Hepatitis Sourcebook, Revised Edition, gives you frank assessments of the latest therapies and drugs. It also provides advice on how you can navigate the day-to-day challenges of living with a liver disorder, and diet and nutrition guidelines, including the truth about the effectiveness of herbal remedies and liver-cleansing diets. |
 |
Native Remedies Liver Doctor and Detox Drops ComboPack by Native Remedies The ComboPack of Liver Dr. and Detox Drops consists of multiple remedies that work well together to provide increased support for your condition. This ComboPack helps to improve liver functioning and aids in detoxifying the system. The Liver Dr. helps to improve liver health and functioning while the Detox Drops assist in the elimination of toxins from the body. |
 |
The Cleveland Clinic Guide to Liver Disorders (Cleveland Clinic Guides) by Nizar Zein (Author), Kevin M Edwards (Author) Expert medical advice from a hospital that has pioneered treatments for liver diseases
More than 25 million people face some type of liver disorder each year. And yet the liver is one of the most important organs in the body.
In The Cleveland Clinic Guide to Liver Disorders, Dr. Nizar N. Zein and nurse Kevin M. Edwards, health experts on the forefront of liver health, provide critical, potentially life-saving information readers need to fight these diseases. This important resource gives readers the cutting-edge medical guidance this physician-nurse team offers its patients, including:
* Information about what the liver does—and what happens when the liver becomes fatty or hardened with scars * The latest research on treating liver infections, fighting liver... |
 |
Schiff's Diseases of the Liver (2 Volume Set) by Michael F. Sorrell (Author), Eugene R. Schiff (Editor), Michael, F. Sorrell (Editor), Willis C. Maddrey (Editor) Univ. of Miami, FL. Brandon/Hill Medical List. Two-volume text on the clinical and basic science aspects of liver disease. For practitioners, residents, and students. Color and halftone illustrations. Previous edition was titled: Diseases of the Liver, by Leon Schiff, c1993. DNLM: Liver Diseases. |
 |
PetAlive Immunity and Liver Support for Protection Against Disease (60 Caps) by PetAlive PetAlive Immunity and Liver Support capsules contain a combination of especially selected herbs known for their ability to cleanse and purify the system, improve immune functioning and support liver health. Used as a general tonic or to protect against disease, Immunity and Liver Support capsules are also very effective during convalescence and can help your pet in the recovery phase after illness. Use PetAlive Immunity and Liver Support to boost immune functioning and resistance against disease and infection, including viral and bacterial infection; improve liver health and functioning and aid in the elimination of systemic toxins; act as a tonic for the lymphatic system; help to counter the harmful effects of frequent vaccinations and antibiotic treatment; promote and speed up healing... |
 |
Holistic Approach to Liver Diseases by Jean Grandoit (Author) |
 |
Livers & Heart Disease Little Teeth (Primary Contributor) |
| © 2009 BrightSurf.com |